Feeling Hungry on Mounjaro: What's Normal and What Isn't

What the trial data actually shows about appetite on tirzepatide

The SURMOUNT-1 trial enrolled 2,539 adults with obesity and tracked them for 72 weeks. Average weight loss reached around 20–21% at the 15mg dose, but that result accumulated across many months of gradually increasing doses, not in the first injection or two. The NHS tirzepatide medicines page explains that tirzepatide activates both GIP and GLP-1 receptors, which together slow how quickly the stomach empties and signal fullness to the brain. Both pathways take time to have their full effect, and the degree of appetite suppression varies from person to person. Some participants in SURMOUNT-1 noticed a dramatic drop in hunger within the first fortnight; others found it crept in more quietly over several months. Neither pattern is wrong. The point is that feeling hungry on Mounjaro, especially early on or at a lower dose, sits well within what the evidence predicts. It does not mean the medicine is failing.

It also helps to understand what the starter dose is designed to do. The 2.5mg pen your treatment begins with exists primarily so your digestive system adjusts without overwhelming side effects, nausea, particularly, tends to be worse if the dose climbs too fast. Weight-loss effects become more pronounced as titration continues, and so does appetite suppression for most people.

The doses where hunger is most likely to linger

The pattern our prescribers see most consistently is that hunger is most noticeable at 2.5mg and 5mg, and often eases noticeably somewhere between 7.5mg and 10mg. That is not universal (some people feel the shift earlier, some later) but it tracks with the pharmacology. GIP and GLP-1 receptor activation is dose-dependent, meaning higher occupancy of those receptors tends to produce stronger appetite signals to the brain. If you are still hungry on Mounjaro at your current dose and have been on it for four weeks or more, that timing matters: your prescriber needs to know before deciding whether to move to the next strength. Dose changes are not automatic, they follow a clinical review of how you are tolerating the current dose and how your weight is responding.

Some people also find that hunger returns around day three or four of their weekly injection cycle, before the next dose is due. If that pattern sounds familiar, the page on day-three hunger on Mounjaro covers the pharmacokinetics in more detail. The short version is that tirzepatide's blood concentration peaks a day or two after injection and then falls, some people feel that fall.

What you eat can close the gap

Tirzepatide slows gastric emptying, but it does not make every food equally filling. Meals built around lean protein (eggs, fish, chicken, legumes) and foods high in soluble fibre tend to stay in the stomach longer, which compounds the medicine's own slowing effect. Meals that are mostly refined carbohydrates digest relatively quickly regardless of how slowly your stomach is moving, and that can leave a hunger gap in the mid-afternoon even on an effective dose. The what to eat on Mounjaro page goes into practical detail about food choices that work alongside the medicine.

Hydration is worth mentioning separately. Thirst and hunger share enough neurological overlap that mild dehydration can register as an appetite signal. A glass of water before a meal, and keeping fluid intake steady through the day, costs nothing and sometimes takes the edge off hunger that the medicine hasn't fully addressed yet. For anyone wondering about specific foods (pasta, for instance) the answer is more nuanced than a flat yes or no, and the page on eating pasta on Mounjaro addresses that directly.

When to tell your prescriber, and when not to worry

Mild, manageable hunger (especially in the first month or at your current starting dose) is normal and does not require urgent action. It is worth logging what you notice: when hunger peaks, how it relates to your injection day, and whether it is changing over time. That information is genuinely useful at your next clinical review. A question our prescribers hear most weeks is whether hunger means the medicine isn't working; usually the answer is that it is working, just not yet at full effect for that individual.

Hunger that feels as strong as before you started, that returns sharply after a period of suppression, or that is accompanied by other changes (mood, energy, unexpected weight gain) is worth raising sooner rather than later. If you have questions between reviews, our support team is available seven days a week. For context on what the opposite experience looks like, the page explaining why some people feel no hunger at all on Mounjaro is a useful companion read. You can also learn more about how tirzepatide works as a treatment on the Mounjaro overview page.

Tirzepatide is a prescription-only medicine. If you are thinking about starting treatment, a free consultation with one of our GPhC-registered prescribers is the place to begin. Start your free consultation and a clinician (not software) will review your answers the same day.